254 related articles for article (PubMed ID: 19152588)
1. The ABCB1-1Delta mutation is not responsible for subchronic neurotoxicity seen in dogs of non-collie breeds following macrocyclic lactone treatment for generalized demodicosis.
Bissonnette S; Paradis M; Daneau I; Silversides DW
Vet Dermatol; 2009 Feb; 20(1):60-6. PubMed ID: 19152588
[TBL] [Abstract][Full Text] [Related]
2. Vincristine-induced central neurotoxicity in a collie homozygous for the ABCB1Δ mutation.
Krugman L; Bryan JN; Mealey KL; Chen A
J Small Anim Pract; 2012 Mar; 53(3):185-7. PubMed ID: 22122243
[TBL] [Abstract][Full Text] [Related]
3. ABCB1-1 Delta (MDR1-1 Delta) genotype is associated with adverse reactions in dogs treated with milbemycin oxime for generalized demodicosis.
Barbet JL; Snook T; Gay JM; Mealey KL
Vet Dermatol; 2009 Apr; 20(2):111-4. PubMed ID: 19171022
[TBL] [Abstract][Full Text] [Related]
4. Canine ABCB1 and macrocyclic lactones: heartworm prevention and pharmacogenetics.
Mealey KL
Vet Parasitol; 2008 Dec; 158(3):215-22. PubMed ID: 18922637
[TBL] [Abstract][Full Text] [Related]
5. Review of prevalence, genetic aspects and adverse effects of the mdr1-1Delta mutation in dogs.
Fecht S; Distl O
Dtsch Tierarztl Wochenschr; 2008 Jun; 115(6):212-9. PubMed ID: 18605373
[TBL] [Abstract][Full Text] [Related]
6. Breed distribution of the ABCB1-1Delta (multidrug sensitivity) polymorphism among dogs undergoing ABCB1 genotyping.
Mealey KL; Meurs KM
J Am Vet Med Assoc; 2008 Sep; 233(6):921-4. PubMed ID: 18795852
[TBL] [Abstract][Full Text] [Related]
7. Biliary excretion of technetium-99m-sestamibi in wild-type dogs and in dogs with intrinsic (ABCB1-1Delta mutation) and extrinsic (ketoconazole treated) P-glycoprotein deficiency.
Coelho JC; Tucker R; Mattoon J; Roberts G; Waiting DK; Mealey KL
J Vet Pharmacol Ther; 2009 Oct; 32(5):417-21. PubMed ID: 19754906
[TBL] [Abstract][Full Text] [Related]
8. Identification of potential biomarkers of P-glycoprotein substrate neurotoxicity in transgenic mice expressing the mutated canine ABCB1 gene.
Zhu M; Ming Y; Swaim H; Swain MD; Myers MJ; Deaver C; Wu X; Jones YL; Yancy HF
Am J Vet Res; 2014 Dec; 75(12):1104-10. PubMed ID: 25419811
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the canine mdr1-1Delta mutation in the dog breed Elo.
Fecht S; Wöhlke A; Hamann H; Distl O
J Vet Med A Physiol Pathol Clin Med; 2007 Oct; 54(8):401-5. PubMed ID: 17877579
[TBL] [Abstract][Full Text] [Related]
10. Intravenous fat emulsion as treatment for ivermectin toxicosis in three dogs homozygous for the ABCB1-1Δ gene mutation.
Wright HM; Chen AV; Talcott PA; Poppenga RH; Mealey KL
J Vet Emerg Crit Care (San Antonio); 2011 Dec; 21(6):666-72. PubMed ID: 22316260
[TBL] [Abstract][Full Text] [Related]
11. Oral bioavailability of P-glycoprotein substrate drugs do not differ between ABCB1-1Δ and ABCB1 wild type dogs.
Mealey KL; Waiting D; Raunig DL; Schmidt KR; Nelson FR
J Vet Pharmacol Ther; 2010 Oct; 33(5):453-60. PubMed ID: 20840389
[TBL] [Abstract][Full Text] [Related]
12. ABCB1 gene polymorphisms are not associated with treatment outcome in elderly acute myeloid leukemia patients.
van der Holt B; Van den Heuvel-Eibrink MM; Van Schaik RH; van der Heiden IP; Wiemer EA; Vossebeld PJ; Löwenberg B; Sonneveld P
Clin Pharmacol Ther; 2006 Nov; 80(5):427-39. PubMed ID: 17112800
[TBL] [Abstract][Full Text] [Related]
13. Neurotoxic effects of ivermectin administration in genetically engineered mice with targeted insertion of the mutated canine ABCB1 gene.
Orzechowski KL; Swain MD; Robl MG; Tinaza CA; Swaim HL; Jones YL; Myers MJ; Yancy HF
Am J Vet Res; 2012 Sep; 73(9):1477-84. PubMed ID: 22924731
[TBL] [Abstract][Full Text] [Related]
14. Canine multi-drug resistance-1 mutation prevalence: A South African perspective.
le Roux-Pullen L; van der Zwan H
J S Afr Vet Assoc; 2014 Nov; 85(1):1139. PubMed ID: 25686216
[TBL] [Abstract][Full Text] [Related]
15. ABCB1-1Delta polymorphism can predict hematologic toxicity in dogs treated with vincristine.
Mealey KL; Fidel J; Gay JM; Impellizeri JA; Clifford CA; Bergman PJ
J Vet Intern Med; 2008; 22(4):996-1000. PubMed ID: 18537875
[TBL] [Abstract][Full Text] [Related]
16. Development of a PCR-based diagnostic test detecting a nt230(del4) MDR1 mutation in dogs: verification in a moxidectin-sensitive Australian Shepherd.
Geyer J; Döring B; Godoy JR; Moritz A; Petzinger E
J Vet Pharmacol Ther; 2005 Feb; 28(1):95-9. PubMed ID: 15720521
[TBL] [Abstract][Full Text] [Related]
17. The MDR1/ABCB1 gene, a high-impact risk factor for cardiac transplant rejection.
Barnard JB; Richardson S; Sheldon S; Fildes J; Pravica V; Hutchinson IV; Leonard CT; Yonan N
Transplantation; 2006 Dec; 82(12):1677-82. PubMed ID: 17198259
[TBL] [Abstract][Full Text] [Related]
18. No influence of 3435C>T ABCB1 (MDR1) gene polymorphism on risk of adult acute myeloid leukemia and P-glycoprotein expression in blast cells.
Jamroziak K; Balcerczak E; Cebula B; Janus A; Mirowski M; Robak T
Ther Drug Monit; 2006 Oct; 28(5):707-11. PubMed ID: 17038891
[TBL] [Abstract][Full Text] [Related]
19. Frequency of the nt230 (del4) MDR1 mutation in Collies and related dog breeds in Germany.
Geyer J; Döring B; Godoy JR; Leidolf R; Moritz A; Petzinger E
J Vet Pharmacol Ther; 2005 Dec; 28(6):545-51. PubMed ID: 16343287
[TBL] [Abstract][Full Text] [Related]
20. P-gp substrate-induced neurotoxicity in an Abcb1a knock-in/Abcb1b knock-out mouse model with a mutated canine ABCB1 targeted insertion.
Swain MD; Orzechowski KL; Swaim HL; Jones YL; Robl MG; Tinaza CA; Myers MJ; Jhingory MV; Buckely LE; Lancaster VA; Yancy HF
Res Vet Sci; 2013 Jun; 94(3):656-61. PubMed ID: 23186803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
